Morpheus Pancreatic
Research payments
$7,571,138
Through program year 2025, $7,571,138 in research payments was reported against Morpheus Pancreatic, across 466 payments, paid by Roche Products Limited.
- Paid by
- Roche Products Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,018,291 | 56 |
| 2024 | Research | $626,303 | 53 |
| 2023 | Research | $1,138,189 | 80 |
| 2022 | Research | $1,561,005 | 67 |
| 2021 | Research | $987,443 | 130 |
| 2020 | Research | $1,675,354 | 43 |
| 2019 | Research | $564,553 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.